World Journal of Clinical Oncology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Depar FN, Chaudhary AJ, Hameed J, Abbasi FS, Uzma B, Ali A, Akhtar N, Khan R, Siddiqi A, Riaz S. Cancer stem cell markers, chemotherapy response, and survival in triple-negative breast cancer. World J Clin Oncol 2026; 17(2): 116251 [PMID: 41810343 DOI: 10.5306/wjco.v17.i2.116251]
URL:	https://www.wjgnet.com/2218-4333/full/v17/i2/116251.htm

(47) (49) (0) (0) (0) (1) (1) (931) (4)

Number	Citing Articles
1	Ilya Klabukov, Denis Baranovskii, Daria Eygel, Elena Yatsenko. Letter to the Editor: Cancer stem cell and oncomatrix biomarkers predict chemotherapy response and survival in triple-negative breast cancer. World Journal of Clinical Oncology 2026; 17(7): 120955 doi: 10.5306/wjco.120955 Abstract(61) \| Core Tip(65) \| Full Article(HTML)(268) \| Full Article (PDF)-361K(29) \| Full Article with Cover (PDF)-701K(22) \| Full Article (XML)-38K(21) \| Audio-130K(4) \| Peer-Review Report-186K(30) \| Answering Reviewers-150K(33) \| Times Cited (0) \| Total Visits (340) \| Open
2	Zhenhong Du, Gang Tu, Lingfeng Tang. Interpretable machine learning reveals the synergistic impact of essential hypertension on early recurrence in triple-negative breast cancer. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-59274-4
3	Sunil V Jagtap, Shubham S Jagtap. Prognostic significance of stem cell markers: In triple-negative breast cancers. World Journal of Clinical Oncology 2026; 17(7): 119673 doi: 10.5306/wjco.v17.i7.119673 Abstract(60) \| Core Tip(62) \| Full Article(HTML)(412) \| Full Article (PDF)-389K(112) \| Full Article with Cover (PDF)-726K(50) \| Full Article (XML)-70K(34) \| Audio-197631K(9) \| Peer-Review Report-242K(37) \| Answering Reviewers-349K(34) \| Times Cited (0) \| Total Visits (660) \| Open
4	Tian Fang, Mengxing Zhang, Chang Ma, Min Dong, Xinhao Song, Junqi Wang, Runan Zuo, Jinwei You, Yingfeng Zhao, Shanxiang Jiang, Dawei Guo. Enhancing EGFR Inhibition: Monensin and Erlotinib Synergize to Eliminate Cancer Stem Cells in Canine Mammary Tumours. Veterinary and Comparative Oncology 2026; 24(3) doi: 10.1111/vco.70085

Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.